Compare LEDS & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEDS | BFRI |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | Taiwan | United States |
| Employees | N/A | 94 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 13.2M |
| IPO Year | 2010 | N/A |
| Metric | LEDS | BFRI |
|---|---|---|
| Price | $2.29 | $0.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 64.3K | ★ 193.8K |
| Earning Date | 04-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.12 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,009,000.00 | N/A |
| Revenue This Year | N/A | $14.36 |
| Revenue Next Year | N/A | $16.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 729.81 | N/A |
| 52 Week Low | $1.01 | $0.54 |
| 52 Week High | $3.37 | $1.19 |
| Indicator | LEDS | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 61.74 | 39.21 |
| Support Level | $1.59 | $0.77 |
| Resistance Level | $2.70 | $0.94 |
| Average True Range (ATR) | 0.28 | 0.08 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 56.47 | 26.02 |
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.